These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 37258443)

  • 1. A Single High Dose of Flufenamic Acid in Rats does not Reduce the Damage Associated with the Rat Lithium-Pilocarpine Model of Status Epilepticus but Leads to Deleterious Outcomes.
    Hernández-Martín N; Gomez F; Silván Á; Rosa RF; Delgado M; Bascuñana P; Pozo MÁ; García-García L
    J Integr Neurosci; 2023 May; 22(3):75. PubMed ID: 37258443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metyrapone prevents brain damage induced by status epilepticus in the rat lithium-pilocarpine model.
    García-García L; Shiha AA; Fernández de la Rosa R; Delgado M; Silván Á; Bascuñana P; Bankstahl JP; Gomez F; Pozo MA
    Neuropharmacology; 2017 Sep; 123():261-273. PubMed ID: 28495374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The vasodilator naftidrofuryl attenuates short-term brain glucose hypometabolism in the lithium-pilocarpine rat model of status epilepticus without providing neuroprotection.
    García-García L; Gomez F; Delgado M; Fernández de la Rosa R; Pozo MÁ
    Eur J Pharmacol; 2023 Jan; 939():175453. PubMed ID: 36516936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PET Imaging and Neurohistochemistry Reveal that Curcumin Attenuates Brain Hypometabolism and Hippocampal Damage Induced by Status Epilepticus in Rats.
    Slowing K; Gomez F; Delgado M; Fernández de la Rosa R; Hernández-Martín N; Pozo MÁ; García-García L
    Planta Med; 2023 Apr; 89(4):364-376. PubMed ID: 36130709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonin Depletion Does not Modify the Short-Term Brain Hypometabolism and Hippocampal Neurodegeneration Induced by the Lithium-Pilocarpine Model of Status Epilepticus in Rats.
    García-García L; Shiha AA; Bascuñana P; de Cristóbal J; Fernández de la Rosa R; Delgado M; Pozo MA
    Cell Mol Neurobiol; 2016 May; 36(4):513-9. PubMed ID: 26208805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subacute administration of fluoxetine prevents short-term brain hypometabolism and reduces brain damage markers induced by the lithium-pilocarpine model of epilepsy in rats.
    Shiha AA; de Cristóbal J; Delgado M; Fernández de la Rosa R; Bascuñana P; Pozo MA; García-García L
    Brain Res Bull; 2015 Feb; 111():36-47. PubMed ID: 25541342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in glucose metabolism and metabolites during the epileptogenic process in the lithium-pilocarpine model of epilepsy.
    Lee EM; Park GY; Im KC; Kim ST; Woo CW; Chung JH; Kim KS; Kim JS; Shon YM; Kim YI; Kang JK
    Epilepsia; 2012 May; 53(5):860-9. PubMed ID: 22429025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PET imaging identifies anti-inflammatory effects of fluoxetine and a correlation of glucose metabolism during epileptogenesis with chronic seizure frequency.
    Bankstahl M; Jahreis I; Wolf BJ; Ross TL; Bankstahl JP; Bascuñana P
    Neuropharmacology; 2024 Dec; 261():110178. PubMed ID: 39369850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ketogenic diet exhibits neuroprotective effects in hippocampus but fails to prevent epileptogenesis in the lithium-pilocarpine model of mesial temporal lobe epilepsy in adult rats.
    Linard B; Ferrandon A; Koning E; Nehlig A; Raffo E
    Epilepsia; 2010 Sep; 51(9):1829-36. PubMed ID: 20633040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastrodin alleviates seizure severity and neuronal excitotoxicities in the rat lithium-pilocarpine model of temporal lobe epilepsy via enhancing GABAergic transmission.
    Yang CS; Chiu SC; Liu PY; Wu SN; Lai MC; Huang CW
    J Ethnopharmacol; 2021 Apr; 269():113751. PubMed ID: 33359863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In the Rat Hippocampus, Pilocarpine-Induced Status Epilepticus Is Associated with Reactive Glia and Concomitant Increased Expression of CD31, PDGFRβ, and Collagen IV in Endothelial Cells and Pericytes of the Blood-Brain Barrier.
    Kyriatzis G; Bernard A; Bôle A; Khrestchatisky M; Ferhat L
    Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuronal degeneration is observed in multiple regions outside the hippocampus after lithium pilocarpine-induced status epilepticus in the immature rat.
    Scholl EA; Dudek FE; Ekstrand JJ
    Neuroscience; 2013 Nov; 252():45-59. PubMed ID: 23896573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between neuronal loss and interictal glucose metabolism during the chronic phase of the lithium-pilocarpine model of epilepsy in the immature and adult rat.
    Dubé C; Boyet S; Marescaux C; Nehlig A
    Exp Neurol; 2001 Feb; 167(2):227-41. PubMed ID: 11161611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ivermectin Exerts Anticonvulsant Effects Against Status Epilepticus Induced by Lithium-Pilocarpine in Rats via GABA
    Manavi MA; Toutounchian S; Afsahi S; Ebrahim Soltani Z; Mohammad Jafari R; Dehpour AR
    Mol Neurobiol; 2024 Oct; 61(10):7627-7638. PubMed ID: 38421468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel Second-Generation EP2 Receptor Antagonist Reduces Neuroinflammation and Gliosis After Status Epilepticus in Rats.
    Rojas A; Amaradhi R; Banik A; Jiang C; Abreu-Melon J; Wang S; Dingledine R; Ganesh T
    Neurotherapeutics; 2021 Apr; 18(2):1207-1225. PubMed ID: 33410110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vigabatrin protects against hippocampal damage but is not antiepileptogenic in the lithium-pilocarpine model of temporal lobe epilepsy.
    André V; Ferrandon A; Marescaux C; Nehlig A
    Epilepsy Res; 2001 Nov; 47(1-2):99-117. PubMed ID: 11673025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycyrrhizin, an HMGB1 inhibitor, exhibits neuroprotective effects in rats after lithium-pilocarpine-induced status epilepticus.
    Li YJ; Wang L; Zhang B; Gao F; Yang CM
    J Pharm Pharmacol; 2019 Mar; 71(3):390-399. PubMed ID: 30417405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1400W, a highly selective inducible nitric oxide synthase inhibitor is a potential disease modifier in the rat kainate model of temporal lobe epilepsy.
    Puttachary S; Sharma S; Verma S; Yang Y; Putra M; Thippeswamy A; Luo D; Thippeswamy T
    Neurobiol Dis; 2016 Sep; 93():184-200. PubMed ID: 27208748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenesis and pharmacology of epilepsy in the lithium-pilocarpine model.
    André V; Dubé C; François J; Leroy C; Rigoulot MA; Roch C; Namer IJ; Nehlig A
    Epilepsia; 2007; 48 Suppl 5():41-7. PubMed ID: 17910580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterisation of NLRP3 pathway-related neuroinflammation in temporal lobe epilepsy.
    Pohlentz MS; Müller P; Cases-Cunillera S; Opitz T; Surges R; Hamed M; Vatter H; Schoch S; Becker AJ; Pitsch J
    PLoS One; 2022; 17(8):e0271995. PubMed ID: 35972937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.